Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

CGTN: Refletindo sobre a batalha de três anos da China contra a COVID em Through the Storm
  • Latin America - español
  • USA - English
  • USA - Pусский
  • USA - español
  • USA - slovenčina
  • USA - Deutsch
  • Middle East - Arabic
  • USA - Français
  • USA - English
  • USA - Polski
  • USA - čeština


News provided by

CGTN

Feb 10, 2023, 13:49 ET

Share this article

Share toX

Share this article

Share toX

PEQUIM, 10 de fevereiro de 2023 /PRNewswire/ -- Desde o início de 2020, a China tem seguido um caminho único para combater a COVID-19. Through the Storm condensa esta batalha de três anos em um documentário de 60 minutos.

Esta apresentação da CGTN tem sua estreia global em 10 de fevereiro. Through the Storm apresenta em primeira mão relatos do surto inicial em Wuhan, a campanha de vacinação em massa, o confinamento em Xangai e, finalmente, a reabertura e recuperação.

Continue Reading
CGTN: Refletindo sobre a batalha de três anos da China contra a COVID em Sobreviver à Tempestade
CGTN: Refletindo sobre a batalha de três anos da China contra a COVID em Sobreviver à Tempestade
Refletindo sobre a batalha de três anos da China contra a COVID em Sobreviver à Tempestade (PRNewsfoto/CGTN)
Refletindo sobre a batalha de três anos da China contra a COVID em Sobreviver à Tempestade (PRNewsfoto/CGTN)

Through the Storm responde a três perguntas essenciais: qual foi o raciocínio da China por trás da escolha de sua abordagem única para combater a COVID? Quais ações a China adotou no período de três anos entre sua vitória em Wuhan e sua reabertura? E a China pode alcançar uma sólida recuperação em2023?

A partir da perspectiva de especialistas em tratamento intensivo na linha de frente, médicos do vilarejo, trabalhadores comunitários, voluntários e tomadores de decisão, o documentário revela as respostas.

AS JANELAS DE OPORTUNIDADES

O que a China enfrentou no início de 2020 foi a cepa original do novo coronavírus, que foi muito mais virulenta e mortal do que a atual cepa da Ômicron. Na época, havia apenas 63.000 camas de UTI para uma população de 1,4 bilhão. Até as melhores mentes médicas da China pareciam impotentes diante deste inimigo desconhecido.

A terrível situação enfrentada por Wuhan poderia ter sido repetida em todo o país. Mas, graças às rigorosas políticas de COVID da China, um desastre nacional foi evitado.

Cerca de 120.000 leitos de UTI foram adicionadas desde o início do surto. Como resultado, a China agora tem mais leitos de UTI por 100.000 pessoas do que países desenvolvidos como Grã-Bretanha, Japão, Espanha e França. Além disso, a equipe médica do país acumulou experiência e habilidade para lidar com a cepa da Ômicron, adotando uma série de protocolos de tratamento atualizados e técnicas de diagnóstico. Ao longo de dois anos, a China vacinou mais de 91% de sua população, com ênfase especial nos idosos.

AS BARREIRAS

Nos três anos que se seguiram ao surto inicial, muita coisa mudou. Desde rigorosos lockdowns comunitários, testes de PCR em massa e a criação de hospitais improvisados, a experiência adquirida e as medidas adotadas em Wuhan foram adotadas e aperfeiçoadas.

Desde 10 de janeiro de 2020, houve um total de 250 dias em que não foram relatados novos casos de COVID. Zhong Nanshan, especialista líder da China em doenças respiratórias, estima que mais de 20 milhões de vidas foram salvas como resultado das rigorosas políticas da anti-COVID da China.

O povo chinês sempre esteve confiante de que poderia derrotar o vírus.

Após as variantes Alfa, Delta e Gama, veio a cepa Ômicron, que infecta o corpo humano 70 vezes mais rápido, mas com sintomas muito menos graves.

As variantes em evolução trouxeram maiores desafios. Em resposta, a China ajustou regularmente suas medidas de prevenção e controle, até que, no final, a decisão foi tomada para fazer uma grande mudança em suas políticas de COVID no final do estudo 2022.

DE VOLTA AOS TRILHOS

Ao longo da pandemia, a China continuou sendo um grande contribuinte para o crescimento econômico global. Nos últimos cinco anos, apesar da instabilidade global, da pandemia e de uma desaceleração doméstica, a China ainda conseguiu alcançar um crescimento médio anual do PIB de 5%.

Um dos principais beneficiários da redução das medidas anti-COVID foi a indústria cinematográfica. A receita de bilheteria durante o feriado de sete dias do Festival da Primavera foi a segunda maior já registrada, totalizando um bilhão de dólares americanos. Durante o mesmo período, mais de 300 milhões de viagens de passageiros foram registradas na rede de transporte do país, gerando receita de 56 bilhões de dólares americanos para o setor de turismo, um aumento de 30% em relação ao ano anterior.

O FMI elevou a estimativa de crescimento do PIB da China de 2023 de 4,4% para 5,2%. A Morgan Stanley é ainda mais otimista, aumentando sua perspectiva de crescimento para 5,7%, conforme uma nota de pesquisa divulgada em janeiro, 0,3 pontos percentuais a mais do que sua estimativa anterior.

Embora o mundo esteja se recuperando gradualmente da pandemia, o novo coronavírus ainda está presente. Para garantir um futuro mais certo para a humanidade, é essencial uma cooperação global maior, mais eficaz e mais ampla.

Vídeo - https://www.youtube.com/watch?v=xzByLHhaCZk 
Foto - https://mma.prnewswire.com/media/2000183/Reflecting_China_s_Three_year_COVID_Battle_Through_Storm.jpg

FONTE CGTN

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

CGTN:Xinjiang en su período más próspero de la historia: libro blanco

Xinjiang de hoy está experimentando el mejor período de desarrollo de su historia, según un libro blanco emitido por la Oficina de Información del...

CGTN: Podle bílé knihy zažívá Sin-ťiang největší rozkvět ve své historii

PEKING, 22. září 2025 /PRNewswire/ – Podle bílé knihy, kterou v pátek zveřejnilo Informační oddělení Státní rady, zažívá dnešní Sin-ťiang...

More Releases From This Source

Explore

Publishing & Information Services

Publishing & Information Services

Computer & Electronics

Computer & Electronics

Multimedia & Internet

Multimedia & Internet

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.